Iridina Infezioni E Infiammazioni (Dexamethasone, Tobramycin)

Dexamethasone acts as a glucocorticoid receptor agonist, suppressing the production of inflammatory mediators in ocular tissues. Tobramycin binds to the bacterial 30S ribosomal subunit, disrupting protein synthesis and causing rapid bacterial cell death. Together they reduce inflammation and eliminate infection.

The dosing regimen for Iridina Infezioni E Infiammazioni is determined by the prescribing clinician based on the specific condition, severity, and patient characteristics. The prescriber will provide instructions on the number of drops, frequency, and duration of therapy.

Safety data for dexamethasone/tobramycin ophthalmic use during pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Iridina Infezioni E Infiammazioni product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Iridina combines a potent corticosteroid (dexamethasone) with a broad‑spectrum aminoglycoside (tobramycin) in a single formulation, offering both anti‑inflammatory and antibacterial activity. Compared with separate eye drops, it simplifies dosing and may improve patient compliance, while providing coverage against many common ocular pathogens.

Store the ophthalmic solution at room temperature, preferably below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from direct light and moisture, and discard any product that appears discolored or contains particles.

The medication is applied as eye drops. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption.

Serious adverse events include severe allergic reactions such as anaphylaxis, corneal ulceration or perforation, and a significant rise in intraocular pressure that could lead to glaucoma or vision loss. Any sudden worsening of vision, eye pain, or swelling should prompt immediate medical attention.

Patients with known hypersensitivity to dexamethasone, tobramycin, or any component of the formulation should avoid the product. It is also contraindicated in individuals with viral eye infections such as herpes simplex keratitis, as corticosteroids may exacerbate the condition.